Analyst Price Targets — ALMR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 12, 2026 11:43 am | — | Leerink Partners | $35.00 | $23.88 | TheFly | Alamar Biosciences initiated with an Outperform at Leerink |
| May 12, 2026 8:36 am | — | Stifel Nicolaus | $28.00 | $23.88 | TheFly | Alamar Biosciences initiated with a Buy at Stifel |
Latest News for ALMR
FREMONT, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in Precision Proteomics dedicated to enabling the earliest detection of disease, today announced it will report financial results for the second quarter 2026 after market close on Monday, August 10, 2026. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m.…
這項全國計劃會採用 Alamar Biosciences 的 NULISAseq Neuro 220 多重檢測組合試劑盒，分析來自 10,000 名阿茲海默症及相關認知障礙症 (ADRD) 參與者約 21,000 份的血漿樣本。 研究所得的數據集將全面開放，經由 National Alzheimer's Coordinating Center 識別碼串聯，並藉全國數據挑戰賽，為人工智能引領的探索揭開序幕。 此計劃隸屬「透過影像技術促進 ADRD 研究清晰度聯盟」(CLARiTI) 的項目組合，憑藉學術、慈善及數據分享的協作力量，成就大規模生物標記探索。 加州菲蒙市, July 14, 2026 (GLOBE NEWSWIRE) -- 精準蛋白質組學領域的領導企業 Alamar Biosciences, Inc. (Nasdaq: ALMR)…
这项全国性研究计划将利用 Alamar Biosciences 的 NULISAseq Neuro 220 检测试剂盒，对 10,000 名阿尔茨海默病及相关痴呆症 (ADRD) 受试者提供的约 21,000 万份血浆样本开展图谱分析。 生成的数据集将对外开放，可通过 National Alzheimer's Coordinating Center (美国国家阿尔茨海默病协调中心) 编号关联调取，并依托全国数据竞赛，支持借助 AI 开展的相关探索研究。 该项目隶属于 ADRD 影像研究清晰度联盟 (CLARiTI) 项目体系，依托学界、公益机构及数据共享的合作资源开展大规模生物标志物挖掘工作。 加利福尼亚州弗里蒙特, July 14, 2026 (GLOBE NEWSWIRE) -- 专注推进疾病早期检测的精准蛋白质组学领军企业 Alamar Biosciences, Inc. (Nasdaq: ALMR)…
Fremont, CA, July 13, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to advancing the early detection of disease, today announced a partnership with leading research universities to launch a national-scale proteomics initiative using Alamar Biosciences' NULISAseq Neuro 220 panel to accelerate biomarker discovery and validation for Alzheimer's disease and…
National-scale initiative will profile ~21,000 plasma samples from 10,000 Alzheimer's Disease and Related Dementias (ADRD) participants using Alamar Biosciences' NULISAseq™ Neuro 220 panel. | Resulting dataset will be publicly accessible, linked through National Alzheimer's Coordinating Center IDs and open to AI-driven discovery through a national data challenge. | Project is part of the Consortium for Clarity in…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ALMR.
U.S. House Trading
No House trades found for ALMR.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.